Hallo zusammen,
ich bin ja echt berührt, wie schnell man sich hier Sorgen macht. Ich lebe noch. Ich war über Pfingsten drei Tage im Kloster und hab die letzten Tage einiges mit der Familie unternommen. Nächste Woche wird bei mir nach drei Chemo-Zyklen Zwischenauswertung gemacht, ich bin schon sehr gespannt.
Gwendas erschütternden Bericht im Thread "Liste der Anhänge anzeigen (Anzahl: 2) Neue Informationen zum Kleinzeller" habe ich gelesen. Wenn ich an meine zahlreichen Lebermetastasen denke und auch daran, dass ich Ende Juni für zweieinhalb Wochen mit der ganzen Familie nach Nordamerika fliegen will, wird mir doch etwas unheimlich ...
Mithilfe einer Suchfunktion habe ich mal hauptsächlich anhand der Datenbank des American Cancer Institute <http://www.cancer.gov/> zusammengetragen, welche aktuellen Studien und Versuchsreihen zur Zeit für den Kleinzeller durchgeführt werden. Vielleicht kann diese Liste ja fuer den einen oder anderen hilfreich sein.
Beste Grüße
Ecki
-
Bevacizumab in Extensive Small Cell Lung Cancer
Phase3 Study of Amrubicin With Cisplatin Versus Etoposide-cisplatin for Extensive Disease Small Cell Lung Cancer
A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer
Topotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lung Cancer and Extensive Disease (SCLC-ED)
Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient
Phase I/II Randomized Study of Combination Chemotherapy Comprising Cisplatin or Carboplatin, and Etoposide With Versus Without Maintenance Sunitinib Malate in Patients With Extensive-Stage Small Cell Lung Cancer (Phase I Closed to Accrual as of 5/17/08)
Carboplatin and Etoposide in Combination With Vorinostat for Patients With Extensive Stage Small Cell Lung Cancer
A Phase 1b/2 Trial of AMG 479 or AMG 102 in Combination With Platinum-based Chemotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer
MK-0646, Etoposide, and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
The SILVA Study - Survival in an international phase III prospective randomized LD small cell lung cancer vaccination study with adjuvant BEC2 and BCG
Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer
Carboplatin and Etoposide Plus LBH589 for Small Cell Lung Cancer
Phase II Pilot Study of Cisplatin, Etoposide, and Cyclophosphamide in Patients With Extensive Stage Small Cell Lung Cancer
Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Metastatic Small Cell Lung Carcinoma
Phase II Study of Paclitaxel Albumin-Stabilized Nanoparticle Formulation (Abraxane) and Carboplatin in Patients With Extensive-Stage Small Cell Lung Cancer
Feasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung Cancer
Phase II Randomized Study of Standard First-Line Chemotherapy Comprising Carboplatin and Etoposide Followed by Observation Versus Autologous Dendritic Cell-Adenovirus p53 Vaccine With Versus Without Tretinoin in Patients With Extensive Stage Small Cell Lung Cancer
Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer
Sunitinib as a Second-line Treatment for Patients With Recurrent Small Cell Lung Cancer
Sorafenib, Cisplatin, and Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer
Phase II Study of Belotecan Hydrochloride and Cisplatin in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung Cancer
Phase II Randomized Study of Topotecan Hydrochloride With Versus Without Aflibercept in Patients With Extensive Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Therapy
Phase II Study of Sunitinib Malate in Patients With Chemotherapy-Naive Extensive Stage or Sensitive Relapsed Small Cell Lung Cancer
A Study of NK012 in Patients With Relapsed Small Cell Lung Cancer
Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC)
Multizentrische, randomisierte, offene Phase III Studie zum Vergleich der Wirksamkeit, Sicherheit und Verträglichkeit von CE konventionell gegen CE dosisintensiviert bei Zugabe von G-CSF in der Therapie des kleinzelligen Bronchialkarzinoms im Stadium extensive disease
A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer
Phase II Randomized Study of Seneca Valley Virus-001 (NTX-010) After Platinum-Based Chemotherapy in Patients With Extensive-Stage Small Cell Lung Cancer
Phase II Study of Paclitaxel, Carboplatin, and Dimethylxanthenone Acetic Acid in Patients With Extensive Stage Small Cell Lung Cancer
An Open-Label, Multicentre, Randomised, Phase III Study Comparing Topotecan/Cisplatin and Topotecan/Etoposide versus Etoposide/Cisplatin as Treatment for Chemotherapy-naïve Patients with Extensive Disease-Small Cell Lung Cancer
The SILVA Study - Survival in an international phase III prospective randomized LD small cell lung cancer vaccination study with adjuvant BEC2 and BCG
Phase I Study of R-(-)-Gossypol, Cisplatin, and Etoposide in Patients With Advanced, Refractory Solid Tumors or Extensive Stage Small Cell Lung Cancer
Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid Tumors
A Study Evaluating the Safety of ABT-263 in Combination With Etoposide/Cisplatin in Subjects With Small Cell Lung Cancer (SCLC)
A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers
A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer
Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Small Cell Lung Cancer
Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung Cancer